Chapter 29 The P2Z/P2X7 receptor of microglial cells: A novel immunomodulatory receptor
- 1 January 1999
- book chapter
- Published by Elsevier
- Vol. 120, 355-368
- https://doi.org/10.1016/s0079-6123(08)63569-4
Abstract
No abstract availableThis publication has 56 references indexed in Scilit:
- Methotrexate and sulfasalazine promote adenosine release by a mechanism that requires ecto-5'-nucleotidase-mediated conversion of adenine nucleotides.Journal of Clinical Investigation, 1998
- The isoquinoline derivative KN‐62 a potent antagonist of the P2Z‐receptor of human lymphocytesBritish Journal of Pharmacology, 1997
- Apoptosis by Death FactorCell, 1997
- Expression of multiple ATP receptor subtypes during the differentiation and inflammatory activation of myeloid leukocytesDrug Development Research, 1996
- The P2Z purinoceptor: an intriguing role in immunity, inflammation and cell deathImmunology Today, 1995
- Extracellular ATP Enhances mRNA Levels of Nitric Oxide Synthase and TNF-α in Lipopolysaccharide-Treated Raw 264.7 Murine MacrophagesBiochemical and Biophysical Research Communications, 1995
- The purinergic P2Z receptor of human macrophage cells. Characterization and possible physiological role.Journal of Clinical Investigation, 1995
- Extracellular ATP Potentiates Nitric Oxide Synthase Expression Induced by Lipopolysaccharide in RAW-264.7 Murine MacrophagesBiochemical and Biophysical Research Communications, 1994
- Extracellular ATP as a possible mediator of cell-mediated cytotoxicityImmunology Today, 1990
- Macrophages and microglia in the nervous systemTrends in Neurosciences, 1988